Filter By:

Results

CTN 090: AZT/3TC/Indinavir (AVANTI II)

A Randomized, Double-blind, Comparative Trial to Evaluate the Efficacy, Safety and Tolerance of Combination Antiretroviral Regimens for the Treatment of HIV-1 Infection: Trial results

Learn More

Results

CTN 089: AZT/3TC/Loviride (AVANTI I)

A Randomized, Double-blind, Comparative Trial to Evaluate the Efficacy, Safety and Tolerance of Combination Antiretroviral Regimens for Treatment of HIV-1 Infection: AZT/3TC vs AZT/3TC/Loviride in Antiretroviral Naïve Patients: Trial results

Learn More

Results

CTN 083: LiGLA

A Phase I Open-Label Study of the Safety and Potential Efficacy of LiGLA (EF-13) in Advanced HIV Infection

Learn More

Results

CTN 081: 3TC, loviride, AZT

A Randomized, Controlled, Double-Blinded Trial to Compare the Efficacy and Safety of 3TC vs 3TC + Loviride vs Placebo in the Treatment of HIV-1-Infected Persons Taking Concurrent AZT Containing Treatment Regimens with CD4s between 25 and 250: Trial results

Learn More

Results

CTN 080: Hydroxyurea with ddI

A pilot study to assess the potential role of hydroxyurea as an adjuvant therapy among patients with advanced HIV disease receiving didanosine (ddI) therapy

Learn More

Results

CTN 067: Nevirapine, ddI, AZT

A randomized, placebo-controlled, double-blinded, multinational trial comparing the immunologic and virologic effects of nevirapine, ddI and AZT combinations for the treatment of antiretroviral naive HIV+ patients with 200 to 600 T-cells and no AIDS-defining disease: Trial results

Learn More

Results

CTN 047: AZT, ddI, ddC

Combination Therapy for Advanced HIV Disease: A Community-based Randomized Trial of the Safety and Laboratory Effects of ZDV/ddI vs ZDV/ddC

Learn More

Results

CTN 016: Acemennan

A Pilot Controlled Double Blind Study of Acemennan in Patients Receiving AZT for the Treatment of Advanced HIV Disease

Learn More